LATEST STATUS: ASPS (representing ~90%+ of U.S. board-certified plastic surgeons) concluded there is insufficient evidence of a favorable risk-benefit ratio for gender-related endocrine and surgical interventions in minors and recommends delaying such surgery until at least age 19; deems WPATH/Endocrine Society/AAP guidance not trustworthy; cites Cass Review and HHS review.
ASPS recommends that surgeons delay gender-related breast/chest, genital, and facial surgery until a patient is at least 19 years old.
LATEST STATUS: ASPS (representing ~90%+ of U.S. board-certified plastic surgeons) concluded there is insufficient evidence of a favorable risk-benefit ratio for gender-related endocrine and surgical interventions in minors and recommends delaying such surgery until at least age 19; deems WPATH/Endocrine Society/AAP guidance not trustworthy; cites Cass Review and HHS review. corroborated by PMC commentary (PMC13258092) and SEGM analysis. A specialty society reviewing interventions its members perform – noted.